Smith & Nephew plc
SNNNYSEHealthcareMedical Devices
As of Oct 26, 2026 close
- Market cap
- $13.11B
- P/E (TTM)
- 11.65
- Forward P/E
- 5.99
- Dividend yield
- 2.57%
- 52-week range
- $26.12$37.51
- Volume (live)
- -
- Avg. volume (3M)
- 1.22M
Smith & Nephew (SNN) Stock Price & Financial Analysis
Smith & Nephew Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $30.33 - $30.64 |
|---|---|
| 52-Week High | $37.51 |
| 52-Week Low | $26.12 |
| Open | $30.54 |
| Volume (last close) | 1.30M |
| Average Volume (3M) | 1.22M |
| Revenue (TTM) | 12.24B |
|---|---|
| Net Income (TTM) | 1.13B |
| Free Cash Flow (TTM) | 1.65B |
| EPS (TTM) | $2.58 |
| Profit Margin | 9.20% |
| Operating Margin | 12.83% |
| Return on Equity (ROE) | 21.74% |
| Debt to Equity | 0.73 |
| Annual Dividend | $0.79 |
|---|---|
| Dividend Yield | 2.57% |
| Payout Ratio | 30.79% |
| Last Dividend Ex-Date | Oct 2, 2026 |
| Market Cap | 13.11B |
|---|---|
| Shares Outstanding | 430.40M |
| P/E Ratio (TTM) | 11.65 |
| Forward P/E | 5.99 |
| Price to Sales (P/S) | 1.07 |
| Price to Book (P/B) | 2.53 |
| EV/EBITDA | 5.79 |
| 50-Day MA | $28.24 |
|---|---|
| 200-Day MA | $31.19 |
| 1-Year Change | −15.37% |
Source: Market prices and company fundamentals. Data as of Oct 26, 2026. Data sources and methodology
Smith & Nephew at a Glance
As of the Oct 26, 2026 close, Smith & Nephew (SNN) has a market capitalization of $13.11B. The stock trades at 11.7× trailing earnings, 6.0× forward earnings and 1.1× sales. Over the trailing twelve months it earned $1.13B on revenue of $12.24B (a 9.2% profit margin) and generated $1.65B of free cash flow. Revenue grew 6.1% year over year.
As of its latest reported balance sheet, it holds $754.00M in cash and securities against $3.79B of debt, a net debt position of $3.03B.
Smith & Nephew pays a semi-annual dividend totaling $0.79 per share a year, a 2.57% yield at the Oct 26, 2026 close, with a 31% payout ratio and 1 consecutive year of dividend increases.
The share price is down 15.4% over the past year. At $30.47 (the Oct 26, 2026 close) it sits within its 52-week range of $26.12 to $37.51, below its 200-day moving average of $31.19.
Based on 6 professional analyst ratings from the past 90 days, the consensus is Hold with an average price target of $28.05, 7.9% below the Oct 26, 2026 close.
Frequently Asked Questions About Smith & Nephew
What is the current stock price for SNN?
As of the Oct 26, 2026 close, SNN stock trades at $30.47. The 52-week range is $26.12–$37.51, with a day range of $30.33–$30.64.
What is the P/E ratio for SNN?
As of the Oct 26, 2026 close, Smith & Nephew's trailing twelve-month (TTM) P/E ratio is 11.7, meaning investors pay $11.7 for every $1 of annual earnings. The forward P/E is 6.0, reflecting analyst expectations for future earnings. Smith & Nephew operates in the Healthcare sector.
Does SNN pay dividends?
Yes, Smith & Nephew pays a 2.57% annual dividend yield as of the Oct 26, 2026 close ($0.79 per share a year). The trailing twelve-month payout ratio is 30.8%. The most recent ex-dividend date was October 2, 2026.
What do analysts recommend for SNN?
Based on ratings from 6 professional analysts over the last 90 days, the consensus for SNN is Hold. The average 12-month price target is $28.05, a 7.9% downside from the Oct 26, 2026 close of $30.47.
What is the market cap of SNN?
As of the Oct 26, 2026 close, Smith & Nephew's market capitalization is $13.11B, classifying it as a large-cap company. Smith & Nephew operates in the Healthcare sector within the Medical Devices industry.